EUVIMEDScopri EUVIMED
Open access · CC BY 4.0

Pan‐Cancer Analysis of Ezrin: A Comprehensive Examination of Its Prognostic Value and Immunological Implications

Ruiqi Chen, Hongbiao Xu, Elfira Jurat, Hewang Huang, Shangwu Yang, Liang Han, Fengyun Wang

Organ Medicine · 2024

DOI: 10.1002/orm2.14 ↗

At a glance

Journal article in Organ Medicine, 2024. Written by Ruiqi Chen and 6 co-authors. Cited 2 times so far (Crossref); 59 references. The full text is freely available (open access, CC BY 4.0).

AbstractDati bibliograficiCiteRelated studies

Abstract (original language)

Background

Ezrin, a member of the ERM protein family, has emerged as a pivotal player in the progression of diverse tumor types and exhibits substantial immunomodulatory capabilities in inflammatory disorders and tumor‐associated immune reactions. Studies have validated the antitumor efficacy of ezrin inhibitors. However, a comprehensive pan‐cancer analysis to fully elucidate the functional implications of ezrin has not been performed.

Methods

Herein, we performed a multifaceted database investigation to evaluate ezrin expression patterns in relation to clinical outcomes, immune checkpoint modulators, prognostic indicators, genomic profiles, and immunological features.

Results

Our analysis revealed distinct ezrin expression patterns across various cancers, with a pronounced association between ezrin expression and immune cell infiltration. Furthermore, drug sensitivity assessments using the GDSC and CTRP databases underscored a robust correlation between ezrin expression and responsiveness to anticancer agents, highlighting its potential as a therapeutic target. Notably, ezrin expression also correlated with patient survival outcomes in the context of anti‐PD1 therapy treatment, suggesting its potential role as a predictive biomarker for immune checkpoint blockade therapies.

Conclusion

Our results indicate ezrin as a promising immunomodulatory target and a valuable diagnostic and prognostic marker for select cancer types. However, the intricate mechanisms underlying ezrin involvement in tumor immune responses necessitate further in‐depth investigation to fully harness its therapeutic and prognostic potential.

Cite

APA

Chen, R., Xu, H., Jurat, E., Huang, H., Yang, S., Han, L., & Wang, F. (2024). Pan‐Cancer Analysis of Ezrin: A Comprehensive Examination of Its Prognostic Value and Immunological Implications. Organ Medicine. https://doi.org/10.1002/orm2.14

Vancouver

Chen R, Xu H, Jurat E, Huang H, Yang S, Han L, et al. Pan‐Cancer Analysis of Ezrin: A Comprehensive Examination of Its Prognostic Value and Immunological Implications. Organ Medicine. 2024. doi:10.1002/orm2.14

BibTeX
@article{Chen2024,
  author = {Chen, Ruiqi and Xu, Hongbiao and Jurat, Elfira and Huang, Hewang and Yang, Shangwu and Han, Liang and Wang, Fengyun},
  title = {Pan‐Cancer Analysis of Ezrin: A Comprehensive Examination of Its Prognostic Value and Immunological Implications},
  journal = {Organ Medicine},
  year = {2024},
  doi = {10.1002/orm2.14}
}
Start for free →